Completion rate, safety, biomarkers, and protective efficacy of 1HP/3HP regimen on latent tuberculosis infection treatment: a multicenter prospective clinical study

Project title

1HP與3HP處方用於潛伏結核感染治療之完成率、安全性、生物標記與保護效力：一個多中心前瞻性臨床研究

Internal ID

MOHW110-CDC-C-114-000103

Principal Investigator

Start Date

January 1, 2021

End Date

December 31, 2021

Investigators

Organizations

Internal Medicine-NTUH

Partner Organizations

Ministry of Health and Welfare